Vahit Ozmen - Dept Gen Surg, Istanbul Univ

基本信息

Career Trajectory

Bio

Bahcesehir Breast Cancer Mammographic Screening Project is a unique population based organized study performed in a developing country, Turkey. It started in 2009 and will continue till 2018. So far 6.500 women aged 40-69 were screened and 53 early breast cancer were detected. 85% of these patients had Stage 0 and I breast cancer.

Research Interests

Papers共 331 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract PS01-01: Feasibility and Oncological Safety of Targeted Axillary Dissection or Sentinel Lymph Node Biopsy in Patients with Clinically Node-Positive Disease after Neoadjuvant Chemotherapy in the Prospective MF-1803 NEOSENTITURK-study

Cancer Researchno. 9_Supplement (2024): PS01-01

Cited0Views0Bibtex

Diagnostic Capabilities of Artificial Intelligence As an Additional Reader in a Breast Cancer Screening Program

Mustafa Ege Seker, Yilmaz Onat Koyluoglu,Ayse Nilufer Ozaydin,Sibel Ozkan Gurdal,Beyza Ozcinar,Neslihan Cabioglu,Vahit Ozmen,Erkin Aribal

European radiologyno. 9 (2024): 6145-6157

Cited0Views0WOSBibtex

Abstract PO4-12-03: PATIENT REPORTED OUTCOMES IN TERMS OF ARM AND SHOULDER FUNCTIONS AND QUALITY OF LIFE AND LYMPHEDEMA ARE AFFECTED BY THE STAGE, AND EXTENT OF AXILLARY SURGERY IN THE EARLY POSTOPERATIVE PERIOD OF PATIENTS WITH BREAST CANCER

Halime Gul Kilic,Selman Emiroglu, Ekin Ozgorgu,Mustafa Tukenmez,Atilla Bozdogan,Mahmut Muslumanoglu,Vahit Ozmen,Dilsad Sindel,Abdullah Igci,Aydan Oral,Neslihan Cabioglu

CANCER RESEARCHno. 9 (2024)

Cited0Views0Bibtex

The Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women with Breast Cancer Who Received Neoadjuvant Chemotherapy

Tuba Kayan Tapan,Filiz Celebi,Kourosh Yaghouti,Filiz Agacayak,Serkan Ilgun,Guersel Soybir,Gul Alco,Naziye Ak,Cetin Ordu,Enver Ozkurt,Caglar Unal,Sevgi Kurt,Alper Ozturk,Zeynep Iyigun,Tomris Duymaz,Vahit Ozmen

EUROPEAN JOURNAL OF BREAST HEALTHno. 2 (2024): 117-121

Cited0Views0WOSBibtex

New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer

Neslihan Cabioglu,Semen Onder,Huseyin Karatay,Aysel Bayram,Gizem Oner,Mustafa Tukenmez,Mahmut Muslumanoglu,Abdullah Igci,Ahmet Dinccag,Vahit Ozmen,Adnan Aydiner,Pinar Saip,Ekrem Yavuz

CANCERSno. 13 (2024)

Cited0Views0WOSBibtex

Outcomes of Reconstructive Techniques in Breast Cancer Using BCCT. Core Software

Sevgi Kurt,Ahmet Serkan İlgün,Enver Özkurt,Gürsel Soybir,Gül Alço,Çağlar Ünal,Filiz Elbüken Çelebi,Tomris Duymaz, Tuğba Kayan Tapan,Naziye Ak,Çetin Ordu,Vahit Özmen

WORLD JOURNAL OF SURGICAL ONCOLOGYno. 1 (2024)

Cited0Views0WOSBibtex

Progressive Relaxation Training in Patients with Breast Cancer Receiving Aromatase Inhibitor Therapy-Randomized Controlled Trial

Umut Bahcaci,Songul Atasavun Uysal,Zeynep Erdogan Iyigun,Cetin Ordu,Gursel Remzi Soybir,Vahit Ozmen

PLOS ONE（2024）

Cited0Views0WOSBibtex

Assessment High-Risk Breast Cancer in Older Patients: A Comparative Analysis of PREDICT Scores and TAILORx Risk Categorization

Caglar Unal,Tolga Ozmen,Cetin Ordu,Cihan Uras,Halil Kara,Erhan Gokmen,Mustafa Ozdogan,Orhan Demircan,Kezban Nur Pilanci,Tomris Duymaz,Vahit Ozmen

Meme sağlığı dergisi/Meme sağlığı dergisino. 4 (2023): 325-330

Cited0Views0WOSBibtex

Evaluation of Benign Breast Diseases With or Without Atypical Epithelial Hyperplasia Accompanying Radial Scars

Zeliha Turkyilmaz,Elif Sarisik,Enver Ozkurt,Mustafa Tukenmez,Selman Emiroglu, Baris Emiroglu,Semen Onder,Ravza Yilmaz,Mahmut Muslumanoglu,Abdullah Igci,Vahit Ozmen,Neslihan Cabioglu

European Journal of Breast Health（2023）

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn